Key result
Antitumor therapy induces treatment-limiting cardiac toxicity, necessitating ongoing efforts to understand its clinical patterns and develop effective preventive strategies.
Why the study?
What are the patterns, clinical course, and potential prevention strategies for cardiac toxicity from antitumor agents?
Population
Patients receiving antitumor therapy
Design
Review
Authors
Loading...
Requires heightened cardiotoxicity awareness in oncology; leaves open optimal prevention strategies pending prospective trials.
What are the patterns, clinical course, and potential prevention strategies for cardiac toxicity from antitumor agents?
This review highlights the clinical course of cardiac toxicity from antitumor agents and discusses emerging strategies for its understanding and prevention.
Praga et al. (2009) studied this question. Antitumor therapy induces treatment-limiting cardiac toxicity, necessitating ongoing efforts to understand its clinical patterns and develop effective preventive strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: